Sign in

CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Elicio Therapeutics, Inc.

Sign in to watch
Ticker
ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113430072
Phone
(857) 209-0050
Business address
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
Former names
Angion Biomedica Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 8-K Event Shareholder vote results
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Derivatives Options or other derivatives
  10. ARS Other Annual Report to Security Holders
  11. DEF 14A Proxy Proxy Statement
  12. 3 Insider Initial Statement of Ownership
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 10-K Report Annual Report
  15. 8-K Event Results of operations
  16. 8-K Event Executive or director change
  17. SCHEDULE 13D/A Stake Beneficial Ownership Report
  18. 4 Conversion Director acquired 3,500,573 shares (conversion)
  19. 8-K Event Unregistered share sale
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 4 of 20 · 384 filings